The Steely Group is seeking a Protein Biochemistry Scientist to join a multidisciplinary research team focused on advancing a prokaryotic protein expression platform. This role will support strain engineering through protein expression optimization, fermentation studies, and protein characterization. The role offers opportunities
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have
Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of
Cartography Biosciences, Inc. in South San Francisco seeks Associate Director or Director of Protein Sciences to lead protein sciences and external manufacturing for clinical programs. The role combines hands-on bench work with managing CDMOs and CROs, and building
Senior Scientist Experimental Protein Design for Target Discovery What you will do In this vital role you will build and lead high-throughput platforms for binder generation, translating computational protein designs into experimentally validated minibinders and antibodies across diverse
About Cartography Biosciences Cartography Biosciences is advancing a differentiated oncology pipeline of antibody-based therapies designed to target tumors with unprecedented precision. The company’s ATLAS and SUMMIT discovery platforms are powered by an industry-leading, fully integrated dataset
Profluent is an AI‑first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Altimeter Capital,
Scientist II, ML – Guided Protein Design Evaluation Emeryville, California, United States; Hybrid (2-3 days on‑site) Profluent is an AI‑first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to
Planet Pharma seeks an Associate Scientist to support protein and antibody production, purification, and analytical workflows in the Discovery Protein Science team. You will execute established protein production programs and ensure high-quality reagents through meticulous record-keeping. The role involves
Join Amgens Mission of Serving Patients At Amgen, if you feel like youre part of something bigger, its because you are. Our shared missionto serve patients living with serious illnessesdrives all that we do. Since 1980,
Cartography Biosciences in South San Francisco is seeking an Associate Director or Director of Protein Sciences to lead protein sciences and external manufacturing for oncology programs. You will oversee CDMO partnerships across development stages, build in‑house expression and analytics
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
About This Role We are seeking a highly motivated and accomplished Senior Scientist with drug discovery experience in diseases with an inflammatory etiology to join our growing Immunology Research Unit in South San Francisco. The ideal
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
When joining PerkinElmer, you select an experienced and trusted leader in scientific solutions, with the support of a global service network and distribution centers, providing the right solution, at the right time, to meet critical customer
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
About GenScript Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its
Prolific Machines is ushering in a new era of biotechnology with light. Our mission is to make next-generation therapies broadly available to patients. Our first-of-its-kind Photomolecular Platform uses light to precisely guide how cells produce complex